230,000 more RSV shots on the way after pressure from Biden officials

Key Facts

• | NIH via AP The White House announced Thursday it struck a deal with drug manufacturers to make available 230,000 more doses of the respiratory syncytial virus shot for infants by January, amid a widespread shortage that’s had parents and pediatricians scrambling to find shots.
• The plan to make more shots available early next year follows weeks of high-level meetings between the Biden administration and a handful of manufacturers, said the three people, who were granted anonymity to detail private conversations.
• Those conversations at times grew tense, two of the people said, with Biden officials faulting company executives for underestimating demand for the shots in their initial projections — and insisting that it would be up to them to ensure the shortfall doesn’t become severe.
• The administration’s intense focus on boosting supply comes amid a rollout of the first RSV shots that has amounted to a test of sorts for how major public health initiatives may play out in the post-Covid era.

Click To Read Full Article